PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Gynecologic cancer expert helps pinpoint best treatment for fast-growing gestational tumors

2011-04-26
(Press-News.org) DALLAS – April 26, 2011 – A clinical trial has sifted out the most effective single-drug chemotherapy regimen for quick-growing but highly curable cancers that arise from the placentas of pregnant women.

In the comparison trial for treating low-risk gestational trophoblastic neoplasia (GTN), researchers found that a biweekly dose of dactinomycin had a higher complete response rate than a weekly dose of methotrexate, the more commonly used drug. GTN is a group of rare tumors that involve abnormal growth of cells inside a woman's uterus.

"Both chemotherapy drugs are effective in treating this kind of neoplasia, but this trial proved that dactinomycin is the best first-line regimen," said Dr. David Scott Miller, who is the head of gynecologic oncology at UT Southwestern Medical Center and co-investigator on the study.

The trial, supported by grants from the National Cancer Institute to the Gynecologic Oncology Group, was published in the March issue of the Journal of Clinical Oncology.

Dr. Miller, professor of obstetrics and gynecology, chairs the uterine corpus committee of the Gynecologic Oncology Group. As group members, UT Southwestern specialists are able to offer patients access to national protocols supported by the institute.

Unlike cervical or endometrial cancers, which develop from cells of the uterus, trophoblastic neoplasia starts in the cells that would normally develop into the placenta during pregnancy. These tumors include hydatidiform moles, caused by over-production of the tissue that typically develops into the placenta, and choriocarcinoma, a quick-growing form of cancer in a woman's uterus.

There has been no consensus on which drug and regimen best treats GTN, and researchers found that such choices were highly institution-specific.

In this trial, researchers compared regimens of both cancer drugs in a sample of 216 women enrolled over an eight-year period. Adverse effects were minimal with either drug, but a biweekly dose of intravenous dactinomycin was superior to a weekly intramuscular injection of methotrexate in stopping the growth of cancerous cells in the uterus. Dactinomycin had a 70 percent complete response rate compared to 53 percent for methotrexate.

Study patients who received dactinomycin also required half the number of treatment cycles. Dactinomycin additionally was easy to administer and had low toxicity – a strong consideration for young reproductive-age women.

"Minimizing toxicity is essential in low-risk GTN, because these women have a high-cure rate and usually hope to have subsequent pregnancies," Dr. Miller said. "These tumors are much more common in developing countries, where access to more complicated chemotherapy regimens is limited. The Gynecological Oncology Group has sought to develop simpler but effective regimens that would lend themselves to use in low-resource settings."

Researchers said further trials comparing the biweekly dactinomycin regimen with other methotrexate regimens are warranted.

### Visit http://www.utsouthwestern.org/obgyn to learn more about clinical services for obstetrics and gynecology at UT Southwestern.

This news release is available on our World Wide Web home page at http://www.utsouthwestern.edu/home/news/index.html

To automatically receive news releases from UT Southwestern via email, subscribe at www.utsouthwestern.edu/receivenews


ELSE PRESS RELEASES FROM THIS DATE:

Antibiotic may prove beneficial to preterm infant lung health

2011-04-26
LEXINGTON, Ky. (April 26, 2011) – A study performed by University of Kentucky researchers shows promise for the use of azithromycin in treating Ureaplasma-colonized or infected premature infants to prevent bronchopulmonary dysplasia (BPD). The study, published in Pediatric Pulmonology, showed subjects colonized or infected with the Ureaplasma bacteria developed BPD or died 73 percent of the time in the azithromycin-treated group, compared to 94 percent of the time in the placebo group. Bronchopulmonary dysplasia is a chronic lung disorder characterized by inflammation ...

Archie's Island Furniture Says a Big "Happy Summer" With Fun New Products

Archies Island Furniture Says a Big "Happy Summer" With Fun New Products
2011-04-26
Archie's Island Furniture, manufacturer of premium painted outdoor furniture, announces the addition of new products to jumpstart summer, in response to the lengthy and brutal New England winter. The new outdoor furniture, expanding Archie's outdoor dining and casual entertaining product lines, offers fun configurations and great color choices for both large and small gatherings. New to the collection this year are an intimately scaled 38" round dining table seating four, porch swings in several lengths and designs, and a coffee table, (42"L, 18"W, 18"H), ...

Novel ash analysis validates volcano no-fly zones

Novel ash analysis validates volcano no-fly zones
2011-04-26
Planes were grounded all over Europe when the Eyjafjallajökull volcano erupted in Iceland last year. But no one knew if the no fly zone was really necessary. And the only way to find out would have been to fly a plane through the ash cloud - a potentially fatal experiment. Now a team of researchers from the University of Copenhagen and the University of Iceland have developed a protocol for rapidly providing air traffic authorities with the data they need for deciding whether or not to ground planes next time ash threatens airspace safety. A study by the teams of Professors ...

Protein inhibitor may bring a topical treatment for HPV

2011-04-26
BOSTON (April 26, 2011) —Human papillomavirus (HPV) causes cervical cancer, the second most common cause of cancer death for women, and is a common cause of anogenital and some head and neck cancers. Thanks to research being done at Tufts University School of Medicine, patients infected with cancer-causing HPV may someday have an alternative to surgical and harsh chemical treatments. In a study funded by the National Institutes of Health and published online in advance of print in The FASEB Journal, the researchers report on the development of a protein-based inhibitor ...

Water molecules characterize the structure of DNA genetic material

Water molecules characterize the structure of DNA genetic material
2011-04-26
Water molecules surround the genetic material DNA in a very specific way. Scientists at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) have discovered that, on the one hand, the texture of this hydration shell depends on the water content and, on the other hand, actually influences the structure of the genetic substance itself. These findings are not only important in understanding the biological function of DNA; they could also be used for the construction of new DNA-based materials. The DNA's double helix never occurs in isolation; instead, its entire surface is ...

Study examines folic acid absorption rates from softgel capsule and standard tablet

2011-04-26
NORTHRIDGE, CA (April 26, 2011) — Folic acid, an essential vitamin formulated to be part of a multivitamin + DHA liquid softgel capsule, is absorbed and available within the body in amounts similar to folic acid formulated for solid tablets, according to a study presented in a late breaking session at the Experimental Biology (EB) 2011 annual meeting. Different formulations, fillers and coatings of vitamin products may affect the degree or rate at which the product dissolves and releases its contents, which can alter the vitamin's absorption into the body and its bioavailability, ...

Motor protein may offer promise in ovarian cancer treatment

2011-04-26
A motor regulatory protein can block human ovarian tumor growth, leading to eventual cancer cell death and possible new therapies to treat the disease, according to Penn State College of Medicine researchers. Among U.S. women, an estimated 21,880 new cases and 13,850 deaths occurred in 2010 from epithelial ovarian cancer, one of the most common forms of ovarian cancer and the most lethal gynecologic cancer in women. Previously, Kathleen M. Mulder, Ph.D., professor, biochemistry and molecular biology, along with members of her laboratory, learned that km23-1 -- a protein ...

Chernobyl's radioactivity reduced the populations of birds of orange plumage

Chernobyls radioactivity reduced the populations of birds of orange plumage
2011-04-26
On April 26, 1986, history's greatest nuclear accident took place northwest of the Ukrainian city of Chernobyl. Despite the scale of the disaster, 25 years later, we still do not know its real effects. An international team of investigators has shown for the first time that the colour of birds' plumage may make them more vulnerable to radioactivity. Radiation causes oxidative stress, damages biological molecules and may have "important" negative effects on organisms in relatively high doses, like those found in certain zones close to Chernobyl. "In the case of the ...

NRL scientists focus on light ions for fast ignition of fusion fuels

2011-04-26
(WASHINGTON) -- Scientists at the Naval Research Laboratory Plasma Physics Division demonstrate significant progress in the efficiency and cost effectiveness of light ions in the fast ignition of fusion targets. Light ions such as lithium or carbon are easier to produce technologically and the ion beam properties can be manipulated and tailored best to suit the necessary requirements for fast ignition. The fast ignition concept has been conceived as an alternative to other approaches for nuclear fusion energy. In the fast ignitor scenario a high-energy particle beam, ...

Erickson Law and The Surrogacy Lawyer Radio Show Offers Free Banner Advertising and Awareness to Infertility Non-Profits In Honor of National Infertility Awareness Week, April 24-30

Erickson Law and The Surrogacy Lawyer Radio Show Offers Free Banner Advertising and Awareness to Infertility Non-Profits In Honor of National Infertility Awareness Week, April 24-30
2011-04-26
In honor of National Infertility Awareness Week, "The Surrogacy Lawyer" Theresa M. Erickson, managing partner of Erickson Law and host of The Surrogacy Lawyer Radio Show on Voice America, announced her firm is offering free banner advertising on its radio show Website to the many infertility nonprofit organizations that offer support, advocacy and education to infertility patients. National Infertility Awareness Week (NIAW) is being held this year from April 24-30 and is the only federally recognized week promoting education and awareness about the disease ...

LAST 30 PRESS RELEASES:

Father’s mental health can impact children for years

Scientists can tell healthy and cancerous cells apart by how they move

Male athletes need higher BMI to define overweight or obesity

How thoughts influence what the eyes see

Unlocking the genetic basis of adaptive evolution: study reveals complex chromosomal rearrangements in a stick insect

Research Spotlight: Using artificial intelligence to reveal the neural dynamics of human conversation

Could opioid laws help curb domestic violence? New USF research says yes

NPS Applied Math Professor Wei Kang named 2025 SIAM Fellow

Scientists identify agent of transformation in protein blobs that morph from liquid to solid

Throwing a ‘spanner in the works’ of our cells’ machinery could help fight cancer, fatty liver disease… and hair loss

Research identifies key enzyme target to fight deadly brain cancers

New study unveils volcanic history and clues to ancient life on Mars

Monell Center study identifies GLP-1 therapies as a possible treatment for rare genetic disorder Bardet-Biedl syndrome

Scientists probe the mystery of Titan’s missing deltas

Q&A: What makes an ‘accidental dictator’ in the workplace?

Lehigh University water scientist Arup K. SenGupta honored with ASCE Freese Award and Lecture

Study highlights gaps in firearm suicide prevention among women

People with medical debt five times more likely to not receive mental health care treatment

Hydronidone for the treatment of liver fibrosis associated with chronic hepatitis B

Rise in claim denial rates for cancer-related advanced genetic testing

Legalizing youth-friendly cannabis edibles and extracts and adolescent cannabis use

Medical debt and forgone mental health care due to cost among adults

Colder temperatures increase gastroenteritis risk in Rohingya refugee camps

Acyclovir-induced nephrotoxicity: Protective potential of N-acetylcysteine

Inhibition of cyclooxygenase-2 upregulates the nuclear factor erythroid 2-related factor 2 signaling pathway to mitigate hepatocyte ferroptosis in chronic liver injury

AERA announces winners of the 2025 Palmer O. Johnson Memorial Award

Mapping minds: The neural fingerprint of team flow dynamics

Patients support AI as radiologist backup in screening mammography

AACR: MD Anderson’s John Weinstein elected Fellow of the AACR Academy

Existing drug has potential for immune paralysis

[Press-News.org] Gynecologic cancer expert helps pinpoint best treatment for fast-growing gestational tumors